Comerica Bank’s PDL BioPharma, Inc. PDLI Stock Holding History

Comerica Bank’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-12,979	Closed	-$108K	–	2322
2014 Q1	$108K	Sell	12,979 -4	-0%	-$34	﹤0.01%	2220
2013 Q4	$110K	Sell	12,983 -435	-3%	-$3.67K	﹤0.01%	2196
2013 Q3	$107K	Sell	13,418 -25	-0.2%	-$201	﹤0.01%	2503
2013 Q2	$104K	Buy	+13,443	New	+$105K	﹤0.01%	2196

Other funds holding PDLI

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Comerica Bank's PDLI Position: Q2 2014 in Review

Comerica Bank sold out of PDL BioPharma, Inc. (PDLI) in Q2 2014, closing a stake of 12,979 shares — an estimated $108K sold.

Comerica Bank first reported a position in PDLI in Q2 2013 and held it in 4 quarters. The position peaked at $110K in Q4 2013. 222 funds tracked by Wall St. Rank hold PDLI as of Q2 2014.

Comerica Bank reported no remaining PDL BioPharma, Inc. position as of Q2 2014 after selling out during the quarter.
Comerica Bank sold 12,979 PDL BioPharma, Inc. shares in Q2 2014, an estimated $108K.
Comerica Bank first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 4 quarters.
Comerica Bank's PDL BioPharma, Inc. position peaked at $110K in Q4 2013.
222 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2014.

Based on Comerica Bank's 13F filing for Q2 2014, filed 12 Aug 2014.